India, Feb. 25 -- The Pharmaceutical Export Promotion Council of India (PHARMEXCIL) supported the India-Brazil Healthcare Business Gateway held at Taj Palace, New Delhi recently, bringing together Indian pharmaceutical manufacturers, regulatory authorities, and Brazilian healthcare leaders.

Organised by Amoveri Farma during the official visit of the Brazilian delegation, the closed-door meeting focused on expanding cooperation in oncology medicines, biosimilars, complex therapies, and hospital technologies, while facilitating structured access to the Brazilian market.

Pharmexcil Chairman Namit Joshi emphasised, "Brazil represents a significant opportunity for Indian MSME pharmaceutical manufacturers, particularly in specialty medicines,...